Presented at IDWeek 2012, HCV Treatment Options: Opportunities for the ID Practice will educate physicians to be able to discuss the benefits and risks of new hepatitis C (HCV) therapies to various patient populations, explain the treatment success/failure rates, analyze the therapy costs and insurance challenges, and develop a working knowledge of the practice infrastructure necessary to treat these patients.